Impact of Prediabetes on In-Hospital Mortality and Clinical Outcomes in Acute Pancreatitis: Insights from a Nationwide Inpatient Sample

<b>Background/Objectives</b>: Prediabetes is characterized by insulin resistance and systemic inflammation, which may increase susceptibility to acute pancreatitis (AP). However, limited data exist on how prediabetes influences in-hospital outcomes in AP patients. This study aimed to evaluate the prevalence and clinical outcomes of hospitalized AP patients with prediabetes using the National Inpatient Sample (NIS) database. <b>Methods</b>: We conducted a retrospective cohort study using NIS data from 2016 to 2018, identifying adult patients hospitalized with a primary diagnosis of AP. Patients were stratified based on the presence or absence of prediabetes; those with type 1 or 2 diabetes were excluded. The primary outcome is the association of prediabetes with developing acute pancreatitis and its influence on in-hospital mortality, length of stay, and total hospital cost. <b>Results</b>: Among 193,617 patients hospitalized with AP, 1639 had prediabetes. No statistically significant difference was found in in-hospital mortality, length of stay, or hospitalization costs between patients with or without prediabetes. The in-hospital mortality was 1.22% in prediabetic patients versus 2.01% in non-prediabetic patients (<i>p</i> = 0.0225). The length of stay was shorter in prediabetic patients (4.93 vs. 5.37 days, <i>p</i> = 0.0021), and hospitalization costs were similar (USD55,351.56 vs. USD57,106.83, <i>p</i> = 0.195). Furthermore, prediabetes was not an independent predictor of mortality (OR 0.50, 95% CI 0.31-0.82, <i>p</i> = 0.0063). Significant predictors of mortality included acute kidney injury (OR 12.98, 95% CI 11.96-14.09, <i>p</i> < 0.001) and severe sepsis with shock (OR 5.89, 95% CI 5.27-6.59, <i>p</i> < 0.001). <b>Conclusions</b>: Prediabetes was not associated with an increased in-hospital mortality in AP patients. However, complications such as AKI and septic shock significantly predicted mortality, underscoring the importance of early recognition and management.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Medicine
Published
2025-06-16
DOI
https://doi.org/10.3390/jcm14124271
Primary Topic
Pancreatitis Pathology and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Impact of Prediabetes on In-Hospital Mortality and Clinical Outcomes in Acute Pancreatitis: Insights from a Nationwide Inpatient Sample

Nelson A. Royall, Shane Robinson, Nawras Silin, Riaz Mahmood et al.
Journal of Clinical Medicine
Pancreatitis Pathology and Treatment
article

Impact of Prediabetes on In-Hospital Mortality and Clinical Outcomes in Acute Pancreatitis: Insights from a Nationwide Inpatient Sample

Nelson A. Royall, Shane Robinson, Nawras Silin, Riaz Mahmood, Tahani Dakkak
article en

Abstract

<b>Background/Objectives</b>: Prediabetes is characterized by insulin resistance and systemic inflammation, which may increase susceptibility to acute pancreatitis (AP). However, limited data exist on how prediabetes influences in-hospital outcomes in AP patients. This study aimed to evaluate the prevalence and clinical outcomes of hospitalized AP patients with prediabetes using the National Inpatient Sample (NIS) database. <b>Methods</b>: We conducted a retrospective cohort study using NIS data from 2016 to 2018, identifying adult patients hospitalized with a primary diagnosis of AP. Patients were stratified based on the presence or absence of prediabetes; those with type 1 or 2 diabetes were excluded. The primary outcome is the association of prediabetes with developing acute pancreatitis and its influence on in-hospital mortality, length of stay, and total hospital cost. <b>Results</b>: Among 193,617 patients hospitalized with AP, 1639 had prediabetes. No statistically significant difference was found in in-hospital mortality, length of stay, or hospitalization costs between patients with or without prediabetes. The in-hospital mortality was 1.22% in prediabetic patients versus 2.01% in non-prediabetic patients (<i>p</i> = 0.0225). The length of stay was shorter in prediabetic patients (4.93 vs. 5.37 days, <i>p</i> = 0.0021), and hospitalization costs were similar (USD55,351.56 vs. USD57,106.83, <i>p</i> = 0.195). Furthermore, prediabetes was not an independent predictor of mortality (OR 0.50, 95% CI 0.31-0.82, <i>p</i> = 0.0063). Significant predictors of mortality included acute kidney injury (OR 12.98, 95% CI 11.96-14.09, <i>p</i> < 0.001) and severe sepsis with shock (OR 5.89, 95% CI 5.27-6.59, <i>p</i> < 0.001). <b>Conclusions</b>: Prediabetes was not associated with an increased in-hospital mortality in AP patients. However, complications such as AKI and septic shock significantly predicted mortality, underscoring the importance of early recognition and management.

Journal of Clinical MedicineVol. 14(12)
Northeast Georgia Medical Center (US)
Openalex Percentile: Top 76%
Pancreatitis Pathology and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.